BUY Sun Pharmaceutical Industries Ltd. — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)6 Nov 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Sun Pharmaceutical Industries rises Monday, outperforms competitors
NewsGoogle News·20 Jul · today
Sun Pharmaceutical Industries Limited has received approval to manufacture and market a generic version of semaglutide in South Africa, expanding its product portfolio and market access.
NSE · Press Release·15 Jul · 6d ago
1 advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·13 Jul · 1w ago
3 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·23 Jun · 4w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Sun Pharmaceutical Industries
- BUY — HSBC Securities7 Oct 2026 · ~1 year · target ₹2,100 · Active
- SELL — Rajesh Palviya, Axis Securities5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY — Sumeet Bagadia, Choice Broking29 Sept 2026 · Same day · target ₹1,875 · Expired
- BUY — 360 One Capital29 Sept 2026 · ~1 year · target ₹2,250 · Active
- BUY — Kotak Securities29 Sept 2026 · ~1 year · target ₹2,150 · Active
More from ICICI Securities
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹969 · Active
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active

